1595. Ceftobiprole Activity against Gram-Positive Pathogens Causing Bone and Joint Infections in the United States from 2016 through 2019

BACKGROUND: Bone and joint infections (BJIs) cause serious morbidity and mortality and present significant treatment challenges. Ceftobiprole medocaril, the prodrug of ceftobiprole, is an advanced cephalosporin approved in many European and non-European countries for the treatment of adults with com...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, Leonard R, Hamed, Kamal, Smart, Jennifer, Pfaller, Michael A, Flamm, Robert K, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777047/
http://dx.doi.org/10.1093/ofid/ofaa439.1775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777047/
http://dx.doi.org/10.1093/ofid/ofaa439.1775

Ejemplares similares